Possible Involvement of the ERK Signaling Cascade in Bipolar Disorder: Behavioral Leads from the Study of Mutant Mice

Drug News and Perspectives

Volumn 16, Issue 7, 2003, Pages 453-463

  Einat, H ^a   Manji, H K ^a   Gould, T D ^a   Du, J ^a   Chen, G ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE RECEPTOR STIMULATING AGENT; LITHIUM; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTROPHIN; PSYCHOSTIMULANT AGENT; VALPROIC ACID;

AFFECT; AGGRESSION; BEHAVIOR; BIPOLAR DISORDER; CLINICAL FEATURE; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; FEEDING BEHAVIOR; GENE MUTATION; GENE TARGETING; GENETIC MANIPULATION; HUMAN; LOCOMOTION; MANIA; MOUSE; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; OPEN FIELD BEHAVIOR; PATHOPHYSIOLOGY; REVIEW; RISK; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ANIMALS; BEHAVIOR, ANIMAL; BIPOLAR DISORDER; HUMANS; LITHIUM; MICE; MICE, MUTANT STRAINS; MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; VALPROIC ACID;

EID: 0344011031     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2003.16.7.829357     Document Type: Review

References (91)

1. Goodwin, F.K. and Jamison, K.R. Manic-Depressive Illness. Oxford University Press, New York, 1990.
2. Sadock, J. and Kaplan, H. Synopsis of Psychiatry. Lippincott and Williams, 2002.
3. Keitner, G.I., Solomon, D.A., Ryan, C.E. et al. Prodromal and residual symptoms in bipolar I disorder. Compr Psychiatry 1996, 37: 362-7.
4. Tohen, M., Hennen, J., Zarate, C.M., Jr. et al. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry 2000, 157: 220-8.
5. Musselman, D.L., Evans, D.L. and Nemeroff, C.B. The relationship of depression to cardiovascular disease: Epidemiology, biology, and treatment. Arch Gen Psychiatry 1998, 55: 580-92.
6. Schulz, R., Beach, S.R., Ives, D.G., Martire, L.M., Ariyo, A.A. and Kop, W.J. Association between depression and mortality in older adults: The Cardiovascular Health Study. Arch Intern Med 2000, 160: 1761-8.
7. Thomas, A.J., Perry, R., Barber, R., Kalaria, R.N. and O'Brien, J.T. Pathologies and pathological mechanisms for white matter hyperintensities in depression. Ann N Y Acad Sci 2000, 977: 333-9.
8. Lopez, A.D. and Murray, C.C. The global burden of disease, 1990-2020. Nat Med 1998, 4: 1241-3.
9. Lenox, R.H., Gould, T.D. and Manji, H.K. Endophenotypes in bipolar disorder. Am J Med Genet 2002, 114: 391-406.
10. Prathikanti, S. and McMahon, F.J. Genome scans for susceptibility genes in bipolar affective disorder. Ann Med 2001, 33: 257-62.
11. Manji, H.K. and Lenox, R.H. The nature of bipolar disorder J Clin Psychiatry 2000, 61(Supp 13): 42-57.
12. Wehr, T.A., Wirz-Justice, A., Goodwin, F.K., Duncan, W. and Gillin, J.C. Phase advance of the circadian sleep-wake cycle as an antidepressant. Science 1979, 206: 710-3.
13. Bunney, W.E. and Bunney, B.G. Molecular clock genes in man and lower animals: Possible implications for circadian abnormalities in depression. Neuropsychopharmacol 2000, 22: 335-45.
14. Gould, T.D. and Manji, H.K. Signaling networks in the pathophysiology and treatment of mood disorders. J Psychosom Res 2002, 53: 687-97.
15. Drevets, W.C. Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog Brain Res 2000, 126: 413-31.
16. Bourne, H.R. and Nicoll, R. Molecular machines integrate coincident synaptic signals. Cell 1993, 72(Suppl): 65-75.
17. Weng, G., Bhalla, U.S. and Iyengar, R. Complexity in biological signaling systems. Science 1999, 284: 92-6.
18. Bhalla, U.S. and Iyengar, R. Emergent properties of networks of biological signaling pathways. Science 1999, 283: 381-7.
19. Mazzucchelli, C. and Brambilla, R. Ras-related and MAPK signalling in neuronal plasticity and memory formation. Cell Mol Life Sci 2000, 57: 604-11.
20. Sweatt, J.D. The neuronal MAP kinase cascade: A biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem 2001, 76: 1-10.
21. Gutkind, J.S. Regulation of mitogen-activated protein kinase signaling networks by G protein-coupled receptors. Sci STKE 2000, 2000: RE1.
22. Thiels, E. and Klann, E. Extracellular signal-regulated kinase, synaptic plasticity, and memory. Rev Neurosci 2001, 12: 327-45.
23. Crespo, P., Xu, N., Simonds, W.F. and Gutkind, J.S. Ras-dependent activation of MAP kinase pathway mediated by G-protein beta gamma subunits. Nature 1994, 369: 418-20.
24. Murga, C., Fukuhara, S. and Gutkind, J.S. Novel molecular mediators in the pathway connecting G-protein-coupled receptors to MAP kinase cascades. Trends Endocrinol Metab 1999, 10: 122-7.
25. Poo, M.M. Neurotrophins as synaptic modulators. Nat Rev Neurosci 2001, 2: 24-32.
26. Patapoutian, A. and Reichardt, L.F. Trk receptors: Mediators of neurotrophin action. Curr Opin Neurobiol 2001, 11: 272-80.
27. Riccio, A., Pierchala, B.A., Ciarallo, C.L. and Ginty, D.D. An NGF-TrkA-mediated retrograde signal to transcription factor CREB in sympathetic neurons. Science 1997, 277: 1097-100.
28. Bonni, A., Brunet, A., West, A.E., Datta, S.R., Takasu, M.A. and Greenberg, M.E. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 1999, 286: 1358-62.
29. Matsubara, M., Kusubata, M., Ishiguro, K., Uchida, T., Titani, K. and Taniguchi, H. Site-specific phosphorylation of synapsin I by mitogen-activated protein kinase and Cdk5 and its effects on physiological functions. J Biol Chem 1996, 271: 21108-13.
30. Kornhauser, J.M. and Greenberg, M.E. A kinase to remember: Dual roles for MAP kinase in long-term memory. Neuron 1997, 18: 839-42.
31. Fukunaga, K. and Miyamoto, E. Role of MAP kinase in neurons. Mol Neurobiol 1998, 16: 79-95.
32. Robinson, M.J., Stippec, S.A., Goldsmith, E., White, M.A. and Cobb, M.H. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite out-growth and cell transformation. Curr Biol 1998, 8: 1141-50.
33. Suzuki, T., Okumura-Noji, K. and Nishida, E. ERK2-type mitogen-activated protein kinase (MAPK) and its substrates in postsynaptic density fractions the rat brain. Neurosci Res 1995, 22: 277-85.
34. Martin, K.C., Michael, D., Rose, J.C. et al. MAP kinase translocates into the nucleus of the presynaptic cell and is required for long-term facilitation in Aplysia. Neuron 1997, 18: 899-912.
35. English, J.D. and Sweatt, J.D. Activation of p42 mitogen-activated protein kinase in hippocampal long term potentiation. J Biol Chem 1996, 271: 24329-32.
36. English, J.D. and Sweatt, J.D. A requirement for the mitogen-activated protein kinase cascade in hippocampal long term potentiation. J Biol Chem 1997, 272: 19103-6.
37. Atkins, C.M., Selcher, J.C., Petraitis, J.J., Trzaskos, J.M. and Sweatt, J.D. The MAPK cascade is required for mammalian associative learning. Nat Neurosci 1998, 1: 602-9.
38. Crow, T., Xue-Bian, J.J., Siddiqi, V., Kang, Y. and Neary, J.T. Phosphorylation of mitogen-activated protein kinase by one-trial and multi-trial classical conditioning. J Neurosci 1998, 18: 3480-7.
39. Blum, S., Moore, A.N., Adams, F. and Dash, P.K. A mitogen-activated protein kinase cascade in the CA1/CA2 subfield of the dorsal hippocampus is essential for long-term spatial memory. J Neurosci 1999, 19: 3535-44.
40. Murphy, T.H., Blatter, L.A., Bhat, R.V., Fiore, R.S., Wier, W.G. and Baraban, J.M. Differential regulation of calcium/calmodulin-dependent protein kinase 11 and p42 MAP kinase activity by synaptic transmission. J Neurosci 1994, 14: 1320-31.
41. Xu, Q., Fawcett, T.W., Gorospe, M., Guyton, K.Z., Liu, Y. and Holbrook, N.J. Induction of mitogen-activated protein kinase phosphatase-1 during acute hypertension. Hypertension 1997, 30: 106-11.
42. Roberson, E.D., English, J.D., Adams, J.P., Selcher, J.C., Kondratick, C. and Sweatt. J.D. The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus. J Neurosci 1999, 19: 4337-48.
43. Roberson, E.D., English, J.D. and Sweatt, J.D. A biochemist's view of long-term potentiation. Learn Mem 1996, 3: 1-24.
44. Ying, S.W., Futter, M., Rosenblum, K. et al. Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: Requirement for ERK activation coupled to CREB and upregulation of Arc synthesis. J Neurosci 2002, 22: 1532-40.
45. Kovalchuk, Y., Hanse, E., Kafitz, K.W. and Konnerth, A. Postsynaptic induction of BDNF-mediated long-term potentiation. Science 2002, 295: 1729-34.
46. Einat, H., Yuan, P., Gould, T.D. et al. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci 2003, 23: 7311-6.
47. Yuan, P.X., Huang, L.D., Jiang, Y.M., Gutkind, J.S., Manji, H.K. and Chen, G. The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. J Biol Chem 2001, 276: 31674-83.
48. Finkbeiner, S. CREB couples neurotrophin signals to survival messages. Neuron 2000, 25: 11-4.
49. Segal, R.A. and Greenberg, M.E. Intracellular signaling pathways activated by neurotrophic factors. Annu Rev Neurosci 1996, 19: 463-89.
50. Thoenen, H. Neurotrophins and neuronal plasticity. Science 1995, 270: 593-8.
51. Pettmann, B. and Henderson, C.E. Neuronal cell death. Neuron 1998, 20: 633-47.
52. Chen, G., Zeng, W.Z., Yuan, P.X. et al. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 1999, 72: 879-82.
53. Manji, H.K., Bebchuk, J.M., Moore, G.J., Glitz, D., Hasanat, K.A. and Chen, G. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: Therapeutic implications. J Clin Psychiatry 1999, 60(Suppl 2): 27-39; discussion 40-1, 113-6.
54. Manji, H.K., Chen, G., Hsiao, J.K., Masana, M.I., Moore, G.J. and Potter, W.Z. Regulation of signal transduction pathways by mood stabilizing agents: Implications for the pathophysiology and treatment of bipolar affective disorder. In: Bipolar Medications: Mechanisms of Action. R.H. Belmaker (Ed.). 1st ed. American Psychiatric Press, Washington, D.C., 2000, 129-77.
55. Rajkowska, G. Histopathology of the prefrontal cortex in major depression: What does it tell us about dysfunctional monoaminergic circuits? Prog Brain Res 2000, 126: 397-412.
56. Manji, H.K. and Chen, G. Post-receptor signaling pathways in the pathophysiology and treatment of mood disorders. Curr Psychiatry Rep 2000, 2: 479-89.
57. Chen, R.W. and Chuang, D.M. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem 1999, 274: 6039-42.
58. Lu, R., Song, L. and Jope, R.S. Lithium attenuates p53 levels in human neuroblastoma SH-SY5Y cells. Neuroreport 1999, 10: 1123-5.
59. Nonaka, S. and Chuang, D.M. Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats. Neuroreport 1998, 9: 2081-4.
60. Chen, G., Rajkowska, G., Du, F., Seraji-Bozorgzad, N. and Manji, H.K. Enhancement of hippocampal neurogenesis by lithium. J Neurochem 2000, 75: 1729-34.
61. Manji, H.K., Drevets, W.C. and Charney, D.S. The cellular neurobiology of depression. Nat Med 2001, 7: 541-7.
62. Rajkowska, G., Miguel-Hidalgo, J.J., Wei, J. et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999, 45: 1085-98.
63. Rajkowska, G., Halaris, A. and Selemon, L.D. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry 2001, 49: 741-52.
64. Miguel-Hidalgo, J.J. and Rajkowska, G. Morphological brain changes in depression: Can antidepressants reverse them? CNS Drugs 2002, 16: 361-72.
65. Tsai, G. and Coyle, J.T. N-acetylaspartate in neuropsychiatric disorders. Prog Neurobiol 1995, 46: 531-40.
66. Moore, G.J., Bebchuk, J.M., Hasanat, K. et al. Lithium increases N-acetyl-aspartate in the human brain: In vivo evidence in support of bcl-2's neurotrophic effects? Biol Psychiatry 2000, 48: 1-8.
67. Moore, G.J., Bebchuk, J.M., Wilds, I.B., Chen. G. and Manji, H.K. Lithium-induced increase in human brain grey matter. Lancet 2000, 356: 1241-2.
68. Einat, H., Kofman, O. and Belmaker, R.H. Animal models of bipolar disorder: From a single episode to progressive cycling models. In: Contemporary Issues in Modeling Psychopharmacology. M. Myslobodsky and I. Weiner (Eds.). Kluwer Academic Publishers, Boston, 2000, 165-80.
69. Einat, H., Belmaker, R.H. and Manji, H. New approaches to modeling bipolar disorder. Psychopharmacol Bull 2003, 37: 47-63.
70. Willner, P. Animal models of depression: Validity and applications. In: Depression and Mania: From Neurobiology to Treatment. G.L. Gessa, W. Fratta, L. Pani and G. Serra (Eds.). Raven Press, New York, 1995, 19-42.
71. Willner, P. Behavioral models in psychopharmacology. In: Behavioral Models in Psychopharmacology: Theoretical, Industrial and Clinical Perspectives. P. Willner (Ed.). Cambridge University Press, Cambridge, 1991, 3-19.
72. Post, R.M. and Weiss, S.R. Emergent properties of neural systems: How focal molecular neurobiological alterations can affect behavior. Dev Psychopathol 1997, 9: 907-29.
73. Crawley, J.N. What's Wrong With My Mouse?: Behavioral Phenotyping of Transgenic and Knockout Mice. 1st ed. Wiley-Liss, New York, 2000.
74. Deckert, J. The adenosine A2A receptor knockout mouse: A model for anxiety? Int J Neuropsychopharmcol 1998, 1: 187-90.
75. Dockstader, C.L. and van der Kooy, D. Mouse strain differences in opiate reward learning are explained by differences in anxiety, not reward or learning. J Neurosci 2001, 21: 9077-81.
76. Ramboz, S., Oosting, R., Amara, D.A. et al. Serotonin receptor 1A knockout: An animal model of anxiety-related disorder. Proc Natl Acad Sci USA 1998, 95: 14476-81.
77. Kofman, O., Belmaker, R.H., Stern, J. and Stern, S. Animal models of mania and bipolar affective disorders. In: Anxiety, Depression and Mania. P. Soubrie (Ed.). Karger, New York, 1991, 103-21.
78. Klein, R.L., Lewis, M.H., Muzyczka, N. and Meyer, E.M. Prevention of 6-hydroxy-dopamine-induced rotational behavior by BDNF somatic gene transfer. Brain Res 1999, 847: 314-20.
79. Kernie, S.G., Liebl, D.J. and Parada, L.F. BDNF regulates eating behavior and locomotor activity in mice. Embo J 2000, 19: 1290-300.
80. Pelleymounter, M.A., Cullen, M.J., Baker, M.B. T. et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995, 269: 540-3.
81. Selcher, J.C., Nekrasova, T., Paylor, R., Landreth, G.E. and Sweatt, J.D. Mice lacking the ERK1 isoform of MAP kinase are unimpaired in emotional learning. Learn Mem 2001, 8: 11-9.
82. Mazzucchelli, C., Vantaggiato, C., Ciamei, A. et al. Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. Neuron 2002, 34: 807-20.
83. Geyer, M.A., Mcllwain, K.L. and Paylor, R. Mouse genetic models for prepulse inhibition: An early review. Mol Psychiatry 2002, 7: 1039-53.
84. Dluzen, D.E., Gao, X., Story, G.M., Anderson, L.I., Kucera, J. and Walro, J.M. Evaluation of nigrostriatal dopaminergic function in adult +/+ and +/- BDNF mutant mice. Exp Neurol 2001, 170: 121-8.
85. Morozov, A., Yin, D., Malleret, G. et al. Generation and characterization of mice with the conditional knockout of BDNF. Soc Neurosci 2001, 686.8.
86. Post, R.M. and Weiss, S.R. Sensitization, kindling, and anticonvulsants in mania. J Clin Psychiatry 1989, 50(Suppl): 23-30; discussion 45-7.
87. Horger, B.A., Iyasere, C.A., Berhow, M.T., Messer, C.J., Nestler, E.J. and Taylor, J.R. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J Neurosci 1999, 19: 4110-22.
88. Lyons, W.E., Mamounas, L.A., Ricaurte, G.A. et al. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci USA 1999, 96: 15239-44.
89. Casper, R.C., Redmond, D.E., Jr., Katz, M.M., Schaffer, C.B., Davis, J.M. and Koslow, S.H. Somatic symptoms in primary affective disorder. Presence and relationship to the classification of depression. Arch Gen Psychiatry 1985, 42: 1098-104.
90. Nibuya, M., Morinobu, S. and Duman, R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995, 15: 7539-47.
91. MacQueen, G.M., Ramakrishnan, K., Croll, S.D. et al. Performance of hererozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression. Behav Neurosci 2001, 115: 1145-53.